Cardiac MRI may lead to targeted PAH therapy

Patients at greatest risk of dying from pulmonary arterial hypertension (PAH) may be identified through cardiac magnetic resonance imaging (MRI) and the information the noninvasive scan provides about the functional level of the heart’s right ventricle.
Source: EurekaAlert, https://www.eurekalert.org